MENU
+Compare
REVS
ETF ticker: NYSE ARCA
AS OF
Apr 4 closing price
Price
$22.67
Change
-$1.37 (-5.70%)
Net Assets
63.49M

REVS stock forecast, quote, news & analysis

The investment seeks investment results that, before fees and expenses, closely correspond to the performance of the Beta Advantage® Research Enhanced U... Show more

Category: #Large Value
REVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
Ad is loading...
A.I.Advisor
a Summary for REVS with price predictions
Apr 04, 2025

REVS sees MACD Histogram crosses below signal line

REVS saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on April 03, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 42 instances where the indicator turned negative. In of the 42 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on April 03, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on REVS as a result. In of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

REVS moved below its 50-day moving average on March 04, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for REVS crossed bearishly below the 50-day moving average on March 10, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where REVS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for REVS entered a downward trend on March 24, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for REVS's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where REVS advanced for three days, in of 355 cases, the price rose further within the following month. The odds of a continued upward trend are .

REVS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are JPMorgan Chase & Co (NYSE:JPM), Exxon Mobil Corp (NYSE:XOM), Procter & Gamble Company (NYSE:PG), Johnson & Johnson (NYSE:JNJ), Oracle Corp (NYSE:ORCL), Bank of America Corp (NYSE:BAC), Salesforce (NYSE:CRM), Wells Fargo & Co (NYSE:WFC), Cisco Systems (NASDAQ:CSCO), Caterpillar (NYSE:CAT).

Industry description

The investment seeks investment results that, before fees and expenses, closely correspond to the performance of the Beta Advantage® Research Enhanced U.S. Value Index. The fund invests at least 80% of its assets in the securities of the index. The index reflects a rules-based strategic beta approach to investing in the companies that comprise the Russell 1000® Value Index, designed to achieve stronger total return when compared to the Russell 1000® Value Index, which is a broad measure of the performance of U.S. large- and mid-cap value companies.

Market Cap

The average market capitalization across the Columbia Research Enhanced Value ETF ETF is 35.98B. The market cap for tickers in the group ranges from 345.08M to 573.02B. JPM holds the highest valuation in this group at 573.02B. The lowest valued company is NLOP at 345.08M.

High and low price notable news

The average weekly price growth across all stocks in the Columbia Research Enhanced Value ETF ETF was -9%. For the same ETF, the average monthly price growth was -10%, and the average quarterly price growth was -9%. MOH experienced the highest price growth at 7%, while MKSI experienced the biggest fall at -26%.

Volume

The average weekly volume growth across all stocks in the Columbia Research Enhanced Value ETF ETF was 116%. For the same stocks of the ETF, the average monthly volume growth was 81% and the average quarterly volume growth was 175%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 51
P/E Growth Rating: 50
Price Growth Rating: 60
SMR Rating: 55
Profit Risk Rating: 48
Seasonality Score: 2 (-100 ... +100)
View a ticker or compare two or three
REVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

Category LargeValue

Profile
Fundamentals
Details
Category
Large Value
Address
Columbia ETF Trust I225 Franklin Street, Boston, MassachusettsBoston
Phone
617-426-3750
Web
N/A